Shareholding disclosure
JPMorgan Chase & Co
Declared position
3.052%
Threshold
Crossed upwards
Timeline
Published
30.07.2015
Transaction
24.07.2015
Voting rights breakdown
Notice details
Notification ID
TAF7T00028
Beneficial owner
JPMorgan Chase & Co
Declared address
JPMorgan Chase & Co., NY 10017/ New York
Relationship between JPMorgan Chase & Co. and the subsidiaries holding shares in Newron Pharmaceuticals SpA at 24 July 2015 JPMorgan Chase & Co. JPMorgan Asset Management Ho1dings Inc. (100%) JPMorgan Asset Management Intemationa1 Limited (100%) JPMorgan Asset Management Holdings (UK) Limited (l00%) JPMorgan Asset Management (UK) Limited (100%) Business Addresses JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017,United States JPMorgan Asset Management Ho1dings Inc., 270 Park Avenue,New York, NY 10017, United States JPMorgan Asset Management International Limited, 60 Victoria Embankment, London EC4Y 0JP, United Kingdom JPMorgan Asset Management Holdings (UK) Limited, 60 Victoria Embankment, London EC4Y 0JP, United Kingdom JPMorgan Asset Management (UK) Limited, 60 Victoria Embankment, London EC4Y 0JP, United Kingdom Registered Addresses JPMorgan Chase & Co., c/o The Corporation Trust Company,1209 Orange Street, Wilmington, Delaware, DE 19081, United States JPMorgan Asset Management Holdings Inc., c/o The Corporation Trust Company, 1209 Orange Street,Wilmington,Delaware, DE 19081, United States JPMorgan Asset Management International Limited, 25 Bank Street, Canary Wharf, London E145JP, United Kingdom JPMorgan Asset Management Holdings (UK) Limited, 25 Bank Street, Canary Wharf, London E145JP, United Kingdom JPMorgan Asset Management (UK) Limited, 25 Bank Street,Canary Wharf, London E145JP, United Kingdom
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan